{
    "organizations": [],
    "uuid": "252a1ec17acbb97bb2f5269fbf12b5a205f7ddf4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eidos-therapeutics-announces-a-640/brief-eidos-therapeutics-announces-a-64-0-mln-series-b-financing-idUSFWN1RI0F4",
    "ord_in_thread": 0,
    "title": "BRIEF-Eidos Therapeutics Announces A $64.0 Mln Series B Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Eidos Therapeutics :\n* ANNOUNCES A $64.0 MILLION SERIES B FINANCING * FINANCING LED BY RA CAPITAL MANAGEMENT AND BRIDGEBIO PHARMA, JANUS HENDERSON, VIKING GLOBAL INVESTORS, AMONG OTHERS Source text for Eikon:\n ",
    "published": "2018-04-05T20:13:00.000+03:00",
    "crawled": "2018-04-06T21:57:02.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "eidos",
        "therapeutic",
        "announces",
        "million",
        "series",
        "b",
        "financing",
        "financing",
        "led",
        "ra",
        "capital",
        "management",
        "bridgebio",
        "pharma",
        "janus",
        "henderson",
        "viking",
        "global",
        "investor",
        "among",
        "others",
        "source",
        "text",
        "eikon"
    ]
}